Evidence map›Paper›PMID 40044276›Full record

ArticleBMJ evidence-based medicine2025

Rating certainty when the target threshold is the null and the point estimate is close to the null.

Linan Zeng, Monica Hultcrantz, David Tovey, Nancy Santesso, Philipp Dahm, Romina Brignardello-Petersen, Reem A Mustafa, M Hassan Murad, Ariel Izcovich, Hans de Beer and 5 more

Abstract read
In one paragraph

Article in BMJ evidence-based medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Linan ZengPharmacy Department/Evidence-based Pharmacy Centre/Children's Medicine Key Laboratory of Sichuan Province, West China Second University Hospital, Sichuan University; Sichuan University and Key Laboratory of Birth Defects and Related Disease of Women and Children, Ministry of Education, West China Second University Hospital, Chengdu, People's Republic of China.ORCID 0009-0009-5081-3353
Monica HultcrantzHTA Region Stockholm, Solna, Stockholm County, Sweden.
David ToveyJournal of Clinical Epidemiology, Sussex, UK.
Nancy SantessoDepartment of Health Research Methods, Evidence, and Impact, McMaster University, Ontario, Canada, McMaster University, Hamilton, Ontario, Canada.
Philipp DahmMinneapolis Veterans Healthcare System, Minnepolis, Minnesota, USA.ORCID 0000-0003-2819-2553
Romina Brignardello-PetersenDepartment of Health Research Methods, Evidence, and Impact, McMaster University, Ontario, Canada, McMaster University, Hamilton, Ontario, Canada.ORCID 0000-0002-6010-9900
Reem A MustafaDivision of Nephrology and Hypertension, Department of Internal Medicine, University of Kansas Medical Centre, Kansas City, USA, University of Kansas Medical Centre, Kansas City, Kansas, USA.
M Hassan MuradEvidence-based Practice Center, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0001-5502-5975
Ariel IzcovichMedicine Department, Universidad del Salvador, Buenos Aires, Argentina.ORCID 0000-0001-9053-4396
Hans de BeerGuide2Guidance, Utrecht, Netherlands.
Martin Alberto RagusaInternal Medicine Division, Fernandez Hospital, Buenos Aires, Argentina.
Bradley JohnstonDepartment of Nutrition, College of Agriculture and Life Sciences:Texas A&M University; Department of Epidemiology & Biostatistics, School of Public Health:Texas A&M University, Texas A&M University, College Station, Texas, USA.
Lingli ZhangPharmacy Department/Evidence-based Pharmacy Centre/Children's Medicine Key Laboratory of Sichuan Province, West China Second University Hospital, Sichuan University; Sichuan University and Key Laboratory of Birth Defects and Related Disease of Women and Children, Ministry of Education, West China Second University Hospital, Chengdu, People's Republic of China.
Alfonso IorioDepartment of Health Research Methods, Evidence, and Impact, McMaster University, Ontario, Canada, McMaster University, Hamilton, Ontario, Canada.
Gordon GuyattDepartment of Health Research Methods, Evidence, and Impact, McMaster University, Ontario, Canada, McMaster University, Hamilton, Ontario, Canada guyatt@mcmaster.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

When one initially targets the null effect and the point estimate falls close to the null, two challenges exist in rating certainty of evidence. First, when the point estimate is near the null and the data, therefore, suggests little or no effect, rating certainty in a benefit or harm is misleading. Second, since in general the narrower the confidence interval (CI) the more precise the estimate, if the CI is narrow, rating down for imprecision due simply to crossing the null is inappropriate. This paper addresses these issues and provides a solution: to revise the target of certainty rating from a non-zero effect to a little or no effect. This solution requires estimating a range in which the minimal important difference (MID) for benefit and an MID for harm might lie, and thus establishing a range that represents little or no effect. If GRADE (Grading of Recommendations, Assessment, Development, and Evaluations) users are confident that the point estimate represents an effect less than the smallest plausible MID, they will revise their target and rate certainty to a little or no effect. If the entire CI falls within the range of little or no effect, they will not rate down for imprecision. Otherwise (if the CI includes an important effect), they will rate down. Using the solution provided in this paper GRADE users can make an optimal choice of the target of certainty rating.

Indexed as

Evidence-Based MedicineResearch DesignConfidence IntervalsHumansMinimal Clinically Important DifferenceEvidence-Based PracticeHealth

Identifiers

PMID40044276
PMCPMC12171472

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.